For example, HSP990, a novel HSP90 inhibitor with aminopyrimidine structure, exhibited effective anti-cancer actions and entered clinical trials for advanced solid tumors (Table 2).166,428,429 These inhibitors are designed to improve therapeutic efficacy and lower toxicity by leveraging diverse chemical structures and metabolic properties. The gene discussed is HSP90AA1; the disease is cancer.